Chlamydia-psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma

Ann Oncol. 2008 Jan;19(1):194-5. doi: 10.1093/annonc/mdm561. Epub 2007 Dec 10.

Authors

A J M Ferreri, G P Dognini, M Ponzoni, L Pecciarini, M G Cangi, G Santambrogio, A G Resti, C De Conciliis, S Magnino, E Pasini, N Vicari, R Dolcetti, C Doglioni

PMID: 18073219
DOI: 10.1093/annonc/mdm561

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Anti-Bacterial Agents / therapeutic use*
Chlamydophila psittaci / drug effects*
Chlamydophila psittaci / isolation & purification
Chlamydophila psittaci / pathogenicity
Doxycycline / therapeutic use*
Female
Humans
Lymphoma, B-Cell, Marginal Zone / complications
Lymphoma, B-Cell, Marginal Zone / drug therapy*
Lymphoma, B-Cell, Marginal Zone / microbiology
Lymphoma, B-Cell, Marginal Zone / pathology
Male
Middle Aged
Orbital Neoplasms / complications
Orbital Neoplasms / drug therapy*
Orbital Neoplasms / microbiology
Orbital Neoplasms / pathology
Psittacosis / complications
Psittacosis / drug therapy*
Remission Induction
Subcutaneous Tissue

Substances

Anti-Bacterial Agents
Doxycycline